VPAC receptors for VIP and PACAP
- PMID: 12529932
VPAC receptors for VIP and PACAP
Abstract
VIP and PACAP are two prominent neuropeptides that share two common G protein-coupled receptors, VPAC1 and VPAC2, while PACAP has an additional specific receptor, PAC1. This article reviews the present knowledge regarding various aspects of VPAC receptors including: 1) receptor specificity toward natural VIP-related peptides and pharmacology of synthetic agonists or antagonists; 2) genomic organization and chromosomal localization; 3) signaling and established or putative interactions with G proteins or accessory proteins such as RAMPs or PDZ-containing proteins; 4) molecular basis of ligand-receptor interaction as determined by site-directed mutagenesis, construction of receptor chimeras, and structural modeling; 5) constitutively active receptor mutants; 6) short-term (desensitization, internalization, phosphorylation) and long-term (transcription) regulations and transgenic models; 7) receptor polymorphisms.
Similar articles
-
Molecular pharmacology and structure of VPAC Receptors for VIP and PACAP.Regul Pept. 2002 Oct 15;108(2-3):165-73. doi: 10.1016/s0167-0115(02)00099-x. Regul Pept. 2002. PMID: 12220741 Review.
-
VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.Endocrinology. 2005 Feb;146(2):744-50. doi: 10.1210/en.2004-0504. Epub 2004 Oct 28. Endocrinology. 2005. PMID: 15514088
-
A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.Endocrinology. 1999 Mar;140(3):1285-93. doi: 10.1210/endo.140.3.6576. Endocrinology. 1999. PMID: 10067855
-
Pituitary adenylate cyclase-activating polypeptide receptors mediating insulin secretion in rodent pancreatic islets are coupled to adenylate cyclase but not to PLC.Endocrinology. 2002 Apr;143(4):1253-9. doi: 10.1210/endo.143.4.8739. Endocrinology. 2002. PMID: 11897681
-
[Physiological significance of pituitary adenylate cyclase-activating polypeptide (PACAP) in the nervous system].Yakugaku Zasshi. 2002 Dec;122(12):1109-21. doi: 10.1248/yakushi.122.1109. Yakugaku Zasshi. 2002. PMID: 12510388 Review. Japanese.
Cited by
-
Baizhu-Baishao herb pair ameliorates functional constipation and intestinal microflora disorder in rats.Animal Model Exp Med. 2023 Dec;6(6):598-608. doi: 10.1002/ame2.12351. Epub 2023 Oct 20. Animal Model Exp Med. 2023. PMID: 37859536 Free PMC article.
-
Vasoactive intestinal peptide-camptothecin conjugates inhibit the proliferation of breast cancer cells.Peptides. 2007 Sep;28(9):1883-90. doi: 10.1016/j.peptides.2007.04.017. Epub 2007 May 6. Peptides. 2007. PMID: 17580098 Free PMC article.
-
The vasoactive intestinal peptide (VIP) alpha-Helix up to C terminus interacts with the N-terminal ectodomain of the human VIP/Pituitary adenylate cyclase-activating peptide 1 receptor: photoaffinity, molecular modeling, and dynamics.Mol Endocrinol. 2008 Jan;22(1):147-55. doi: 10.1210/me.2007-0361. Epub 2007 Sep 20. Mol Endocrinol. 2008. PMID: 17885205 Free PMC article.
-
VIP/PACAP receptor mediation of cutaneous active vasodilation during heat stress in humans.J Appl Physiol (1985). 2010 Jul;109(1):95-100. doi: 10.1152/japplphysiol.01187.2009. Epub 2010 Apr 15. J Appl Physiol (1985). 2010. PMID: 20395540 Free PMC article.
-
Roles for pituitary adenylate cyclase-activating peptide (PACAP) expression and signaling in the bed nucleus of the stria terminalis (BNST) in mediating the behavioral consequences of chronic stress.J Mol Neurosci. 2010 Nov;42(3):327-40. doi: 10.1007/s12031-010-9364-7. Epub 2010 Apr 20. J Mol Neurosci. 2010. PMID: 20405238 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases